1. Home
  2. VRSK vs KVUE Comparison

VRSK vs KVUE Comparison

Compare VRSK & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRSK
  • KVUE
  • Stock Information
  • Founded
  • VRSK 1971
  • KVUE 2022
  • Country
  • VRSK United States
  • KVUE United States
  • Employees
  • VRSK N/A
  • KVUE N/A
  • Industry
  • VRSK Business Services
  • KVUE Specialty Chemicals
  • Sector
  • VRSK Consumer Discretionary
  • KVUE Consumer Discretionary
  • Exchange
  • VRSK Nasdaq
  • KVUE Nasdaq
  • Market Cap
  • VRSK 40.9B
  • KVUE 41.0B
  • IPO Year
  • VRSK 2009
  • KVUE 2023
  • Fundamental
  • Price
  • VRSK $300.51
  • KVUE $21.44
  • Analyst Decision
  • VRSK Hold
  • KVUE Buy
  • Analyst Count
  • VRSK 10
  • KVUE 12
  • Target Price
  • VRSK $302.40
  • KVUE $25.33
  • AVG Volume (30 Days)
  • VRSK 952.0K
  • KVUE 18.7M
  • Earning Date
  • VRSK 07-30-2025
  • KVUE 08-05-2025
  • Dividend Yield
  • VRSK 0.59%
  • KVUE 3.92%
  • EPS Growth
  • VRSK 27.61
  • KVUE N/A
  • EPS
  • VRSK 6.84
  • KVUE 0.55
  • Revenue
  • VRSK $2,930,700,000.00
  • KVUE $15,302,000,000.00
  • Revenue This Year
  • VRSK $8.93
  • KVUE $2.94
  • Revenue Next Year
  • VRSK $7.23
  • KVUE $3.51
  • P/E Ratio
  • VRSK $44.24
  • KVUE $38.69
  • Revenue Growth
  • VRSK 7.20
  • KVUE N/A
  • 52 Week Low
  • VRSK $257.59
  • KVUE $17.67
  • 52 Week High
  • VRSK $322.92
  • KVUE $25.17
  • Technical
  • Relative Strength Index (RSI)
  • VRSK 41.40
  • KVUE 48.29
  • Support Level
  • VRSK $299.27
  • KVUE $20.48
  • Resistance Level
  • VRSK $308.19
  • KVUE $21.15
  • Average True Range (ATR)
  • VRSK 4.99
  • KVUE 0.38
  • MACD
  • VRSK -0.86
  • KVUE 0.08
  • Stochastic Oscillator
  • VRSK 7.98
  • KVUE 90.59

About VRSK Verisk Analytics Inc.

Verisk Analytics is the leading provider of statistical, actuarial, and underwriting data for the United States' property and casualty insurance industry. Verisk leverages a vast contributory database and proprietary data assets to develop analytical tools helping insurance providers to better assess and price risk, achieve operational efficiency and optimize claim settlement processes. While Verisk also offers tools to quantify costs after loss events occur and to detect fraudulent activity, it is expanding into adjacent markets of life insurance, marketing, and non-US operations.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: